Skip to main content
logo
  • Products
    Overview

    Funds

    • Performance & Yields
    • Liquidity
    • Ultra-Short
    • Short Duration
    • European domiciled products

    Solutions

    • Cash Segmentation
    • Separately Managed Accounts
    • Managed Reserves Strategy

    Fund Information

    • Regulatory Updates
  • Insights
    Overview

    Liquidity Insights

    • Liquidity Insights Overview
    • Case Studies
    • ESG Resources for Liquidity Investors
    • Leveraging the Power of Cash Segmentation
    • Cash Investment Policy Statement

    Market Insights

    • Market Insights Overview
    • Eye on the Market
    • Guide to the Markets
    • Market Updates

    Portfolio Insights

    • Portfolio Insights Overview
    • Currency
    • Fixed Income
    • Long-Term Capital Market Assumptions
    • Sustainable investing
    • Strategic Investment Advisory Group
  • Resources
    Overview
    • MORGAN MONEY
    • Global Liquidity Investment Academy
    • Account Management & Trading
    • Announcements
  • About us
    Overview
    • Diversity, Equity & Inclusion
    • Spectrum: Our Investment Platform
    • Our Leadership Team
  • Contact us
  • English
  • Role
  • Country
MORGAN MONEY LOGIN
Search
Menu
Search
You are about to leave the site Close
J.P. Morgan Asset Management’s website and/or mobile terms, privacy and security policies don't apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan Asset Management isn’t responsible for (and doesn't provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan Asset Management name.
CONTINUE Go Back
  1. Man vs Nature Part II

  • LinkedIn Twitter Facebook

Man vs Nature Part II

06-04-2020

Michael Cembalest

In this week's note, we take a close look at country and regional virus data, and examine the pitfalls of over-extrapolating trends that often reverse. We compare the US and China versions of an "economic lockdown", and unsurprisingly find that they're quite different in terms of magnitude and impact. We conclude with a discussion of convalescent plasma as a COVID-19 treatment, and with charts for investors on why the shape of a recovery is less important than the equity lead time vs the recovery in the real economy.

Continue reading

LISTEN AND SUBSCRIBE TO MICHAEL CEMBALEST

In this podcast series, Michael Cembalest, Chairman of Market and Investment Strategy offers timely commentary on the economy, marekts and investment portfolios
 

Listen on Apple Podcasts

 

Listen on Google Play

Subscribe to RSS Feed

Read more by Michael Cembalest

903c02a82872c26

  • Markets
  • Economy
  • Eye on the Market
J.P. Morgan Asset Management

  • Investment stewardship
  • About us
  • Contact us
  • Privacy policy
  • Cookie policy
  • Sitemap
J.P. Morgan

  • J.P. Morgan
  • JPMorgan Chase
  • Chase

READ IMPORTANT LEGAL INFORMATION. CLICK HERE >

The value of investments may go down as well as up and investors may not get back the full amount invested.

Copyright 2025 JPMorgan Chase & Co. All rights reserved.